Literature DB >> 7117862

Changes in pO2 induce retinal autoregulation in vitro.

N Papst, E Demant, G Niemeyer.   

Abstract

Vascular autoregulation maintains stable retinal function in vivo in the face of changes in arterial pO2. We observed autoregulatory changes in the flow of perfusate through the isolated cat eye in response to changes in pO2. Hydrostatic perfusion pressure and all other variables of the perfusate, except for pO2, were kept constant. Throughout the experiments the viability of the eye was monitored by electroretinography. In nine short periods of hypoxia, pO2 of the perfusate was reduced by 12%-42% compared to the control. In eight of these experiments the flow rate of the perfusate increased significantly. Retinal vasodilation during hypoxia was also documented by indocyanine green angiography, monitored by TV, and photographed. In seven periods of hyperoxia, pO2 was raised by 7%-38%. In all cases the flow of the perfusate decreased. These changes in flow are interpreted as resulting from autoregulative vasodilation and vasoconstriction of the retinal vessels. The b-wave of the ERG increased and decreased parallel with pO2 of the perfusate. This indicates that autoregulation in vitro does not sufficiently compensate for changes in pO2. This is in contrast to our findings from a previous study in the anesthetized cat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117862     DOI: 10.1007/bf02159971

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

Review 1.  REVIEW OF PREVIOUS STUDIES AND CURRENT THEORIES OF AUTOREGULATION.

Authors:  P C JOHNSON
Journal:  Circ Res       Date:  1964-08       Impact factor: 17.367

2.  Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches.

Authors:  A M Laties
Journal:  Arch Ophthalmol       Date:  1967-03

3.  Elimination by hypoxia cerebral blood flow autoregulation and EEG relationship.

Authors:  J Freeman; D H Ingvar
Journal:  Exp Brain Res       Date:  1968       Impact factor: 1.972

4.  Blood gas tensions and acid-base balance in awake cats.

Authors:  D A Herbert; R A Mitchell
Journal:  J Appl Physiol       Date:  1971-03       Impact factor: 3.531

5.  [The electroretinogram of the cat during hypoxia].

Authors:  G C van den Bos
Journal:  J Physiol (Paris)       Date:  1968 May-Jun

6.  The contrast sensitivity of cat retinal ganglion cells at reduced oxygen tensions.

Authors:  C Enroth-Cugell; T K Goldstick; R A Linsenmeier
Journal:  J Physiol       Date:  1980-07       Impact factor: 5.182

7.  Effects of changes in systemic blood pressure on the electroretinogram of the cat: evidence for retinal autoregulation.

Authors:  E Demant; K Nagahara; G Niemeyer
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-11       Impact factor: 4.799

8.  The effect of hyperbaric oxygen on adult rabbit retina.

Authors:  V G Criswick; G S Harris
Journal:  Arch Ophthalmol       Date:  1967-12

9.  Effects of hypoxia and hypercapnia on the light peak and electroretinogram of the cat.

Authors:  R A Linsenmeier; A H Mines; R H Steinberg
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-01       Impact factor: 4.799

10.  Effects of changes in arterial Po2 and Pco2 on the electroretinogram in the cat.

Authors:  G Niemeyer; K Nagahara; E Demant
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-11       Impact factor: 4.799

View more
  10 in total

1.  Retinal and choroidal thickness evaluation by SD-OCT in adults with obstructive sleep apnea-hypopnea syndrome (OSAS).

Authors:  C Xin; J Wang; W Zhang; L Wang; X Peng
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

Review 2.  Retinal pharmacology in the perfused cat eye.

Authors:  G Niemeyer
Journal:  Doc Ophthalmol       Date:  1988 Mar-Apr       Impact factor: 2.379

3.  Structural and functional retinal abnormalities in type 2 diabetes with obstructive sleep apnea.

Authors:  Rajiv Raman; Sangeetha Srinivasan; Ramakrishnan Nagarajan
Journal:  Sleep Breath       Date:  2016-04-26       Impact factor: 2.816

Review 4.  The association between ophthalmologic diseases and obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Leh-Kiong Huon; Stanley Yung-Chuan Liu; Macario Camacho; Christian Guilleminault
Journal:  Sleep Breath       Date:  2016-05-26       Impact factor: 2.816

5.  A method for chorioretinal oxygen tension measurement.

Authors:  Mahnaz Shahidi; Akbar Shakoor; Norman P Blair; Marek Mori; Ross D Shonat
Journal:  Curr Eye Res       Date:  2006-04       Impact factor: 2.424

6.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

7.  Standing potential and c-wave during changes in PO2 and flow in the perfused cat eye.

Authors:  B Kreienbühl; G Niemeyer
Journal:  Doc Ophthalmol       Date:  1985-10-15       Impact factor: 2.379

8.  Effects of buphenine (nylidrin) on the perfused mammalian eye.

Authors:  G Niemeyer; D Cottier; H Resch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

9.  Evaluation of Intraocular pressure, Corneal thickness, and Retinal nerve fiber layer thickness in patients with Obstructive Sleep Apnea Syndrome.

Authors:  Kuddusi Teberik; Mehmet Tahir Eski; Ege Gulec Balbay; Murat Kaya
Journal:  Pak J Med Sci       Date:  2018 Jul-Aug       Impact factor: 1.088

10.  Retinal and Choroidal Effects of Continuous Positive Airway Pressure as Treatment for Sleep Apnea: Results at 12 Months.

Authors:  Pedro Naranjo-Bonilla; Rafael Giménez-Gómez; María Del Carmen Muñoz-Villanueva; Bernabé Jurado-Gámez
Journal:  Int J Environ Res Public Health       Date:  2022-10-03       Impact factor: 4.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.